Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
Launched by TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER, EL PASO · Nov 25, 2020
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon**
This clinical trial is studying a new method of examining the small intestine, which is often needed for patients experiencing unexplained gastrointestinal bleeding, anemia, or iron deficiency. The researchers want to see how deep they can insert a special balloon device called the Through-the-Scope (TTS) balloon during a procedure known as retrograde enteroscopy, compared to using a standard colonoscope alone. The goal is to find out if this new method can help doctors access more areas of the small intestine more effectively while providing real-time examination and treatment options.
To participate in this study, individuals must be between 18 and 90 years old and need to have certain medical conditions that require this specific type of endoscopy. Participants will be asked to sign an informed consent form and will undergo the procedure at the University Medical Center of El Paso, Texas. The trial is currently recruiting patients, and those who qualify will have the opportunity to help advance medical knowledge while receiving care for their condition. It’s important to note that some individuals, such as pregnant women or those with certain medical histories, may not be eligible for the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Sign Informed Consent Form
- • 2. Patients age between 18-90 years
- 3. Patients in which retrograde enteroscopy is indicated for any of the following:
- • abnormal video capsule endoscopy non-diagnostic upper and lower endoscopy obscure gastrointestinal bleeding iron deficiency anemia non-diagnostic upper endoscopy and abnormal CT Hemodynamically stable
- Exclusion Criteria:
- • 1. Inability to sign Informed Consent Form
- • 2. Pregnancy and breast feeding
- • 3. Prior colon resection
- • 4. Patients with known strictures
- • 5. Patients with altered anatomy
- • 6. Inadequate bowel preparation.
About Texas Tech University Health Sciences Center, El Paso
Texas Tech University Health Sciences Center, El Paso is a leading academic institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent sponsor of clinical trials, the center focuses on improving patient outcomes by rigorously investigating new therapies and treatment protocols across various medical disciplines. With a commitment to excellence and ethical standards, Texas Tech El Paso fosters collaboration among researchers, healthcare professionals, and community partners to address pressing health challenges and enhance the quality of care in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
El Paso, Texas, United States
Patients applied
Trial Officials
Marc J Zuckerman, MD
Principal Investigator
Texas Tech University Health Sciences Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials